Qube Research & Technologies (QRT)’s Bellicum Pharmaceuticals BLCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-15,760
Closed -$56K – 2548
2020
Q4
$56K Sell
15,760
-25,601
-62% -$108K ﹤0.01% 1690
2020
Q3
$272K Buy
+41,361
New +$280K ﹤0.01% 1282

Other funds holding BLCM

Qube Research & Technologies (QRT)'s BLCM Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Bellicum Pharmaceuticals (BLCM) in Q1 2021, closing a stake of 15,760 shares — an estimated $56K sold.

Qube Research & Technologies (QRT) first reported a position in BLCM in Q3 2020 and held it in 2 quarters. The position peaked at $272K in Q3 2020. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Bellicum Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 15,760 Bellicum Pharmaceuticals shares in Q1 2021, an estimated $56K.
  • Qube Research & Technologies (QRT) first reported a position in Bellicum Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Bellicum Pharmaceuticals position peaked at $272K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.